Literature DB >> 12654655

High-efficiency generation of antibiotic-resistant strains of Streptococcus pneumoniae by PCR and transformation.

Antonio J Martín-Galiano1, Adela G de la Campa.   

Abstract

We designed a method by which to generate antibiotic-resistant strains of Streptococcus pneumoniae at frequencies 4 orders of magnitude greater than the spontaneous mutation rate. The method is based on the natural ability of this organism to be genetically transformed with PCR products carrying sequences homologous to its chromosome. The genes encoding the targets of ciprofloxacin (parC, encoding the ParC subunit of DNA topoisomerase IV), rifampin (rpoB, encoding the beta subunit of RNA polymerase), and streptomycin (rpsL, encoding the S12 ribosomal protein) from susceptible laboratory strain R6 were amplified by PCR and used to transform the same strain. Resistant mutants were obtained with a frequency of 10(-4) to 10(-5), depending on the fidelity of the DNA polymerase used for PCR amplifications. Ciprofloxacin-resistant mutants, for which the MICs were four-to eightfold higher than that for R6, carried a single mutation of a residue in the quinolone resistance-determining region: S79 (change to A, F, or Y) or D83 (change to N or V). Rifampin-resistant strains, for which the MICs were at least 133-fold higher than that for R6, contained a single mutation within cluster I of rpoB: S482 (change to P), Q486 (change to L), D489 (change to V), or H499 (change to L or Y). Streptomycin-resistant mutants, for which the MICs were at least 64-fold higher than that for R6, carried a mutation at either K56 (change to I, R, or T) or K101 (change to E). PCR products obtained from the mutants were able to transform R6 to resistance with high efficiency (>10(4)). This method could be used to efficiently obtain resistant mutants for any drug whose target is known.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12654655      PMCID: PMC152537          DOI: 10.1128/AAC.47.4.1257-1261.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  39 in total

1.  Fluoroquinolone resistance in Streptococcus pneumoniae.

Authors:  J Liñares; A G de la Campa; R Pallares
Journal:  N Engl J Med       Date:  1999-11-11       Impact factor: 91.245

2.  Regulation of competence for genetic transformation in Streptococcus pneumoniae by an auto-induced peptide pheromone and a two-component regulatory system.

Authors:  E V Pestova; L S Håvarstein; D A Morrison
Journal:  Mol Microbiol       Date:  1996-08       Impact factor: 3.501

3.  An unmodified heptadecapeptide pheromone induces competence for genetic transformation in Streptococcus pneumoniae.

Authors:  L S Håvarstein; G Coomaraswamy; D A Morrison
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

4.  Structural mechanism for rifampicin inhibition of bacterial rna polymerase.

Authors:  E A Campbell; N Korzheva; A Mustaev; K Murakami; S Nair; A Goldfarb; S A Darst
Journal:  Cell       Date:  2001-03-23       Impact factor: 41.582

5.  Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates.

Authors:  M Heep; B Brandstätter; U Rieger; N Lehn; E Richter; S Rüsch-Gerdes; S Niemann
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

6.  Horizontal transfer of parC and gyrA in fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae.

Authors:  M J Ferrándiz; A Fenoll; J Liñares; A G De La Campa
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

7.  Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae: contributions of type II topoisomerase mutations and efflux to levels of resistance.

Authors:  D J Bast; D E Low; C L Duncan; L Kilburn; L A Mandell; R J Davidson; J C de Azavedo
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

8.  Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknot.

Authors:  M Finken; P Kirschner; A Meier; A Wrede; E C Böttger
Journal:  Mol Microbiol       Date:  1993-09       Impact factor: 3.501

9.  Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain.

Authors:  R Pallares; J Liñares; M Vadillo; C Cabellos; F Manresa; P F Viladrich; R Martin; F Gudiol
Journal:  N Engl J Med       Date:  1995-08-24       Impact factor: 91.245

10.  The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta.

Authors:  J Hofmann; M S Cetron; M M Farley; W S Baughman; R R Facklam; J A Elliott; K A Deaver; R F Breiman
Journal:  N Engl J Med       Date:  1995-08-24       Impact factor: 91.245

View more
  10 in total

1.  New species genetic approach to identify strains of mitis group streptococci that are donors of rifampin resistance to Streptococcus pneumoniae.

Authors:  María-José Ferrándiz; Carmen Ardanuy; Josefina Liñares; Luz Balsalobre; María Teresa García; Adela G de la Campa
Journal:  Antimicrob Agents Chemother       Date:  2010-11-01       Impact factor: 5.191

2.  Fluoroquinolone-resistant pneumococci: dynamics of serotypes and clones in Spain in 2012 compared with those from 2002 and 2006.

Authors:  Arnau Domenech; Jose M Tirado-Vélez; Asunción Fenoll; Carmen Ardanuy; Jose Yuste; Josefina Liñares; Adela G de la Campa
Journal:  Antimicrob Agents Chemother       Date:  2014-02-10       Impact factor: 5.191

3.  New mutations and horizontal transfer of rpoB among rifampin-resistant Streptococcus pneumoniae from four Spanish hospitals.

Authors:  María José Ferrándiz; Carmen Ardanuy; Josefina Liñares; José María García-Arenzana; Emilia Cercenado; Ana Fleites; Adela G de la Campa
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

4.  Fitness of Streptococcus pneumoniae fluoroquinolone-resistant strains with topoisomerase IV recombinant genes.

Authors:  Luz Balsalobre; Adela G de la Campa
Journal:  Antimicrob Agents Chemother       Date:  2007-12-26       Impact factor: 5.191

5.  Streptococcus pneumoniae surface protein PcpA elicits protection against lung infection and fatal sepsis.

Authors:  David T Glover; Susan K Hollingshead; David E Briles
Journal:  Infect Immun       Date:  2008-04-07       Impact factor: 3.441

6.  Genome-Wide fitness analysis of group B Streptococcus in human amniotic fluid reveals a transcription factor that controls multiple virulence traits.

Authors:  Allison N Dammann; Anna B Chamby; Andrew J Catomeris; Kyle M Davidson; Hervé Tettelin; Jan-Peter van Pijkeren; Kathyayini P Gopalakrishna; Mary F Keith; Jordan L Elder; Adam J Ratner; Thomas A Hooven
Journal:  PLoS Pathog       Date:  2021-03-08       Impact factor: 6.823

7.  Fluoroquinolone resistance in penicillin-resistant Streptococcus pneumoniae clones, Spain.

Authors:  Adela G de la Campa; Luz Balsalobre; Carmen Ardanuy; Asunción Fenoll; Emilio Pérez-Trallero; Josefina Liñares
Journal:  Emerg Infect Dis       Date:  2004-10       Impact factor: 6.883

8.  Targeted Curing of All Lysogenic Bacteriophage from Streptococcus pyogenes Using a Novel Counter-selection Technique.

Authors:  Chad W Euler; Barbara Juncosa; Patricia A Ryan; Douglas R Deutsch; W Michael McShan; Vincent A Fischetti
Journal:  PLoS One       Date:  2016-01-12       Impact factor: 3.240

9.  Advancing Genetic Tools in Streptococcus pneumoniae.

Authors:  Haley Echlin; Jason W Rosch
Journal:  Genes (Basel)       Date:  2020-08-20       Impact factor: 4.096

10.  The influence of in vitro fitness defects on pneumococcal ability to colonize and to cause invasive disease.

Authors:  Jenny Fernebro; Christel Blomberg; Eva Morfeldt; Hans Wolf-Watz; Staffan Normark; Birgitta Henriques Normark
Journal:  BMC Microbiol       Date:  2008-04-18       Impact factor: 3.605

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.